Kuku S F, Zeidler A, Emmanouel D S, Katz A I, Rubenstein A H
J Clin Endocrinol Metab. 1976 Jan;42(1):173-6. doi: 10.1210/jcem-42-1-173.
Immunoreactive plasma glucagon (IRG) in normal subjects and patients with chronic renal failure, diabetic ketoacidosis and diagetic hyperosmolar syndrome circulates in several forms. In the diabetic patients most IRG eluted coincidentally with the extracted, purified pancreatic hormone (MW3500), while in normal subjects a high molecular weight component predominated. In striking contrast, the major component of plasma IRG in patients with chronic renal failure was of intermediate size (MW +/- 9000), consistent with proglucagon. The accumulation of this form of IRG suggests that the kidney plays an important role in its metabolism. If there are differences in the biological activity of the various circulating components of IRG, the significance of immunoreactive glucagon levels in some disease states will require reassessment.
正常受试者以及患有慢性肾衰竭、糖尿病酮症酸中毒和糖尿病高渗综合征患者的免疫反应性血浆胰高血糖素(IRG)以多种形式循环。在糖尿病患者中,大多数洗脱的IRG与提取、纯化的胰腺激素(分子量3500)同时出现,而在正常受试者中,高分子量成分占主导。与之形成显著对比的是,慢性肾衰竭患者血浆IRG的主要成分是中等大小(分子量约9000),与胰高血糖素原一致。这种形式的IRG的积累表明肾脏在其代谢中起重要作用。如果IRG各种循环成分的生物活性存在差异,那么在某些疾病状态下免疫反应性胰高血糖素水平的意义将需要重新评估。